William (Qinjie) Tong is currently the Business Unit Head for Respiratory Inhaled at AstraZeneca China, where they drive growth through innovation in the healthcare industry. Previously, they held various leadership roles at AstraZeneca, including Executive Director for Forxiga in China, achieving significant sales growth, and overseeing international commercial planning. Their experience also includes being a Vice President at CBC Group and an Engagement Manager at McKinsey & Company, specializing in the Asia healthcare practice. Earlier in their career, they worked at Procter & Gamble, managing new product launches and supply chain initiatives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices